• Activity INFORMATION

  Overview

  This module is part of the General Pain Specialty Series, which explores overall pain management considerations, best practices, and pain conditions. This module examines the overlapping concerns of pain management and substance use disorder (addiction) and explores the correlation between the rate of overdose deaths and the rate of prescribing of opioid medications. Morphine milligram equivalent dosing is discussed within the context of the CDC's 2016 chronic pain opioid guidelines.
  

  Handouts

  • Slide Document :   22154L08_2pp.pdf Download

  • Slide Document :   22154L08_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recognize how the relative risks of opioid overdoses/deaths correlate with the use of identified higher risk prescription opioid dosage thresholds

  Recall that 75% of heroin utilizers first began opioid utilization with prescription opioids, yet the source of said prescription opioids is outside the realm of healthcare in the majority of cases

  Calculate prescription opioid morphine milligram equivalent (MME) daily dosages for the most common prescription opioid medications based on the 2016 CDC Chronic Pain Opioid Guidelines

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-917161

  Universal Activity Number

  Pharmacist 0798-0000-22-154-L08-P
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Mark  Garofoli, PharmD, MBA, BCGP, CPE, CTTS Assistant Professor, West Virginia University School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).